TP53 and neoplasm: This report showed higher expression of two conserved tumor antigens (MAGEA1 and MAGEA3) in HPV-negative tumors and a significant decrease of TP53 in HPV-positive tumors, but no attempt was made to link together these antigens, nor to assess the degree of B cell tumor infiltrate and clinical benefit.